您的购物车当前为空
OT-551 HCl 是一种 NF-Κb 抑制剂,是一种具有抗氧化特性的二取代羟胺可用于治疗白内障和老年性黄斑变性和地域性萎缩 (GA)。
别名 OT-551 HCl(627085-11-4 Free base)
OT-551 HCl 是一种 NF-Κb 抑制剂,是一种具有抗氧化特性的二取代羟胺可用于治疗白内障和老年性黄斑变性和地域性萎缩 (GA)。

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 780 | 现货 | |
| 5 mg | ¥ 1,730 | 现货 | |
| 10 mg | ¥ 2,570 | 现货 | |
| 25 mg | ¥ 4,110 | 现货 | |
| 50 mg | ¥ 5,850 | 现货 | |
| 100 mg | ¥ 8,120 | 现货 | |
| 200 mg | ¥ 10,900 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,010 | 现货 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
该分子属于定制产品。TargetMol拥有优秀的合成团队,经验和能力,可以为您提供高性价比的产品。
如您有任何问题,欢迎咨询,我们将竭诚为您服务。| 产品描述 | OT-551 HCl is an NF-Κb inhibitor, a disubstituted hydroxylamine with antioxidant properties can be used for the treatment of cataracts and age-related macular degeneration and geographic atrophy (GA). |
| 体内活性 | OT-551 HCl (intraperitoneally injected; rats; approximately 30 min prior to a 6 h exposure to 2700 lux white fluorescent light) significantly reduced the number of RPE cell nuclei in light-exposed eyes from water-treated animals. RPE damage index was significantly lower in the animals treated with any dose of OT-551 HCl compared to water-treated animals both in the inferior and superior hemispheres. Systemic administration of OT-551 HCl provides RPE cell protection against acute light damage.[1] |
| 别名 | OT-551 HCl(627085-11-4 Free base) |
| 分子量 | 277.79 |
| 分子式 | C13H24ClNO3 |
| CAS No. | 627085-15-8 |
| Smiles | Cl.CC1(C)CC(CC(C)(C)N1O)OC(=O)C1CC1 |
| 存储 | |||||||||||||||||||||
| 溶解度信息 | DMSO: 3.6 mg/mL (12.96 mM), Sonication is recommended. | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。 | |||||||||||||||||||||
对于不同动物的给药剂量换算,您也可以参考 更多